Form 101, Part II
نویسنده
چکیده
منابع مشابه
A polymorph of 2,4-dinitrophenylhydrazine
The crystal structure of a previously unreported polymorph (form II) of 2,4-dinitro-phenyl-hydrazine (DNPH), C6H6N4O4, was determined at 90 K. The first polymorph (form I) is described in the monoclinic space group P21/c [Okabe et al. (1993 ▶). Acta Cryst. C49, 1678-1680; Wardell et al. (2006 ▶). Acta Cryst. C62, o318-320], whereas form II is in the monoclinic space group Cc. The mol-ecular str...
متن کاملComplexes With Biologically Active Ligands. Part 101 Inhibition of Carbonic Anhydrase Isozymes I and II With Metal Complexes of Imidazo[2,1−b ]-1,3,4-Thiadiazole-2-Sulfonamide
THE TITLE COMPOUND WAS PREPARED BY AN IMPROVED VARIANT OF THE LITERATURE PROCEDURE, AND METAL COMPLEXES CONTAINING ITS ANION AND THE FOLLOWING METAL IONS: Zn(II), Cd(II), Hg(II), Co(II), Ni(II), Cu(II), V(IV), Fe(III) and Ag(I) were synthesized and characterized by standard procedures (elemental analysis; IR, electronic, NMR and EPR spectroscopy; TG, magnetic and conductimetric measurements). T...
متن کاملContour Crafting Process Plan Optimization Part II: Multi–Machine Cases
Contour Crafting is an emerging technology that uses robotics to construct free form building structures by repeatedly laying down layers of material such as concrete. The Contour Crafting technology scales up automated additive fabrication from building small industrial parts to constructing buildings. Tool path planning and optimization for Contour Crafting benefit the technology by increasin...
متن کاملNEW RECORDS OF FORM-GENUS CYTOSPORA IN IRAN (II)
In a taxonomic study on form-species of form-genus Cytospora, about four hundred fungal specimens were collected from all over the Iran during 2003-2005. In this paper, the second part of the obtained results, including seven form-species are presented. Cytospora intermedia, C. kantschavelii, C. leucosperma and C. ribis are reported as new members for mycoflora of Iran. Salix aegyptiaca for C. ...
متن کاملNeuroendocrine tumors: nursing implications for oral targeted agents and patient management: Part II.
149 Carmen Jacobs, RN, OCN®, is a research nurse supervisor in the Gastrointestinal Medical Oncology Department at the University of Texas M.D. Anderson Cancer Center in Houston. Editorial assistance was provided by Meniscus Health Care Communications through an educational grant from Novartis Pharmaceuticals. Mention of specific products and opinions related to those products do not indicate o...
متن کامل